SMTL ID : 3vw8.1

Crystal structure of human c-Met kinase domain with its inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

1 x DF6: N-({4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}carbamothioyl)-2-phenylacetamide(Non-covalent)

DF6.1: 23 residues within 4Å: Chain A: I.60, V.68, A.84, K.86, E.103, I.106, M.107, V.115, L.116, V.131, L.133, P.134, Y.135, M.136, K.137, G.139, F.176, H.178, M.187, V.196, A.197, D.198, F.199 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:I.60, A:A.84, A:K.86, A:I.106, A:V.115, A:L.116, A:L.133, A:Y.135, A:F.176, A:F.176, A:D.198 Hydrogen bonds: A:E.103, A:M.136, A:D.198

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 7 residues within 4Å: Chain A: T.153, V.154, K.155, F.320, G.322, E.323, H.324 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Matsumoto, S. et al., Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors. Bioorg.Med.Chem. (2013)

Release Date

2013-08-14

Peptides

Hepatocyte growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Hepatocyte growth factor receptor